Publications

Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma

Download PDF
Resource: Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma

.

Related Articles

Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF-Fusion pilocytic astrocytoma

Link
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients

Link